The Expansion of Bispecifics in Myeloma -What’s Next? Alfred Garfall, MD

Bispecific antibodies are changing the treatment landscape for multiple myeloma, offering new hope for patients who have exhausted other options. In this video, Dr. Alfred Garfall discusses how bispecific therapies are expanding beyond the relapsed and refractory setting, what new targets are being explored, and what the future may hold for earlier use and combination strategies.